Nidal Asaad
Hamad Medical Corporation
CardiologyAcute coronary syndromeHeart failureDiabetes mellitusMedicine
What is this?
Publications 145
#1Jakub Gumprecht (University of Liverpool)H-Index: 2
#2Magdalena Domek (University of Liverpool)H-Index: 1
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 143
view all 9 authors...
Atrial fibrillation (AF) is associated with substantially increased risk of cardiovascular events and overall mortality. The Atrial fibrillation Better Care (A—Avoid stroke, B—Better symptom management, C—Cardiovascular and comorbidity risk management) pathway provides a simple and comprehensive approach for integrated AF therapy. This study’s goals were to evaluate the ABC pathway compliance and determine the main gaps in AF management in the Middle East population, and to assess the impact of ...
#1Magdalena Domek (University of Liverpool)H-Index: 1
#2Yan-Guang Li (PKU: Peking University)H-Index: 4
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 143
view all 10 authors...
Abstract Background Atrial fibrillation (AF) poses a great risk of mortality, especially when associated with diabetes mellitus (DM). Objectives We aimed to investigate the rate and risk factors for mortality among AF patients with and without DM in the population from the Middle East where it has never been investigated before. Methods We analyzed the Gulf-SAFE registry, involving patients with nonvalvular AF from the Middle East, for one-year all-cause mortality. The predictive capability of t...
#1Charbel Abi Khalil (Hamad Medical Corporation)H-Index: 13
#2Mohammad Zubaid (Kuniv: Kuwait University)H-Index: 21
Last. Jassim Al Suwaidi (Hamad Medical Corporation)H-Index: 31
view all 6 authors...
Beta-blockers (BB) have been traditionally associated with improvement in cardiovascular disease outcomes in patients with ischemic cardiomyopathy. Whether they’re still efficacious in the post-reperfusion era is currently debated in the light of recent controversial reports. In-hospital, 6-month and 12-month mortality were studied in the GULF-COAST, a prospective multicenter cohort of acute coronary syndrome (ACS), in relation to BB use: prior to admission, 24-hour post-admission and on dischar...
#1Mohammed Al-Jarallah (Amiri Hospital)H-Index: 4
#2Rajesh Rajan (Amiri Hospital)H-Index: 2
Last. Khalid F. AlHabib (KSU: King Saud University)H-Index: 25
view all 18 authors...
Objectives: We sought to estimate the mortality and morbidity in diabetic acute heart failure (AHF) patients stratified by left ventricular ejection fraction. Methods: We analyzed the data of patients with AHF from seven Middle Eastern countries (Bahrain, Oman, Yemen, Kuwait, UAE, Qatar, and Saudi Arabia) from February to November 2012, who were enrolled in a multinational registry of patients with heart failure (HF). Results: A total of 2258 AHF patients had diabetes mellitus. The mean age was ...
#1Mohammad Zubaid (Kuniv: Kuwait University)H-Index: 21
#2Wafa Rashed (Mubarak Al Kabeer Hospital)H-Index: 14
Last. Arif Al MullaH-Index: 1
view all 12 authors...
We describe the characteristics of ambulatory patients with heart failure with reduced ejection fraction (HFrEF) in the Gulf region (Middle East) and the implementation of guideline-recommended tre...
#2Rajesh RajanH-Index: 2
Last. Haitham AminH-Index: 16
view all 18 authors...
AIMS: The aim of this study is to determine the impact of diabetes mellitus on all-cause mortality and rehospitalization rates at 3 months and at 1 year in patients admitted with acute heart failure (AHF) stratified by left ventricular ejection fraction (EF). METHODS AND RESULTS: We analysed consecutive patients admitted to 47 hospitals in seven Middle Eastern countries (Saudi Arabia, Oman, Yemen, Kuwait, United Arab Emirates, Qatar, and Bahrain) with AHF from February to November 2012 with AHF ...
1 CitationsSource
#1Rajesh RajanH-Index: 2
view all 18 authors...
#1Charbel Abi Khalil (Hamad Medical Corporation)H-Index: 1
#1Charbel Abi Khalil (Hamad Medical Corporation)H-Index: 13
Last. Jassim Al Suwaidi (Hamad Medical Corporation)H-Index: 31
view all 17 authors...
BACKGROUND: The prognostic impact of beta-blockers (BB) in coronary artery disease (CAD) is controversial, especially in the post-reperfusion era. OBJECTIVE: To assess whether patients with CAD and heart failure (HF) but without left ventricular dysfunction might benefit from BB use. METHODS: We studied in-hospital cardiovascular events in patients hospitalized for acute HF, with a previous history of CAD and a left ventricular ejection fraction (LVEF) >/=40%, in relation to BB on admission; and...
1 CitationsSource
#1Suhail A. R. Doi (Qatar University)H-Index: 35
#2Nazmul Islam (Qatar University)H-Index: 1
Last. Amar M Salam (Hamad Medical Corporation)H-Index: 12
view all 20 authors...
Background Smoker's paradox has been observed with several vascular disorders, yet there are limited data in patients with acute heart failure (HF). We examined the effects of smoking in patients w...
#1Tam Truong Donnelly (U of C: University of Calgary)H-Index: 17
Last. Rajvir SinghH-Index: 13
view all 5 authors...
Cardiovascular diseases are the leading cause of death worldwide. Among cardiovascular patients, depression is associated with an increased morbidity and mortality. Understanding how depression is conceptualized from cardiovascular patients’ perspective can help with prevention, early detection, and treatment for depression. This might reduce cardiovascular morbidity and mortality, and save health care costs. To the best of our knowledge, there is no study in the Gulf region exploring depression...